Accelerating Our Growth in Life Sciences and Fermentation Services
As part of the corporate growth strategy, BRAINBiocatalysts is pleased to announce that Daren Bryce will lead the Life Sciences and Fermentation Business Unit.
As part of the corporate growth strategy, BRAINBiocatalysts is pleased to announce that Daren Bryce will lead the Life Sciences and Fermentation Business Unit. With increasing demand for enzyme innovation in pharmaceuticals, diagnostics and bioprocessing, we are aligning BRAINBiocatalysts development and manufacturing capabilities to create increased value for our customers. By further increasing the focus in this exciting field we will bundle our service activities in Contract Research (CRO) and Contract Manufacturing (CMO) to accelerate the launch of new products.
The BRAINBiocatalysts Life Science Solutions brand was launched in October 2024 combining BRAIN’s cutting edge enzyme discovery and optimisation experience, with Biocatalysts’ world class commercial-scale manufacturing. With Daren’s extensive experience in both Life Science and fermentation markets, he is perfectly positioned to lead BRAIN Biocatalysts Life Science Solutions and Fermentation Services.
